Carboxyl-terminal domain of human apolipoprotein E: Expression, purification, and crystallization

被引:22
作者
Forstner, M
Peters-Libeu, G
Contreras-Forrest, E
Newhouse, Y
Knapp, M
Rupp, B
Weisgraber, KH [1 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
[2] Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
D O I
10.1006/prep.1999.1144
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thioredoxin fusion expression vectors for two carboxyl-terminal fragments of human apolipoprotein (apo) E (residues 223-272 and 223-299) were generated from an apoE cDNA with the objective of obtaining structural information on this functionally important region of apoE by X-ray crystallography, A thrombin cleavage recognition site was positioned at the fusion junction to release the apoE fragments from the fusion protein. The fusion proteins were expressed in Escherichia coli, isolated from cell lysates by nickel-affinity column chromatography, and cleaved with thrombin, After gel filtration and ion exchange chromatography, yields of each fragment were approximately 14 mg/L, Both fragments bind to the phospholipid dimyristoylphosphatidylcholine in a manner similar to that of the 216-299 fragment of apoE isolated from plasma, which represents the major lipid-binding region of the protein. Orthorhombic crystals of the apoE 223-272 fragment that diffracted to 1.8 Angstrom were obtained in a mixture of 0.1 M imidazole (pH 6.0) and 0.4 M NaOAc (pH 7.0-7.5), containing 30% glycerol. The space group is C222 with cell dimensions of a = 35.17 Angstrom, b = 38.95 Angstrom, and c = 133.27 Angstrom. (C) 1999 Academic Press.
引用
收藏
页码:267 / 272
页数:6
相关论文
共 31 条
[11]   IMPACT OF APOLIPOPROTEIN-E POLYMORPHISM ON LIPOPROTEINS AND RISK OF MYOCARDIAL-INFARCTION - THE ECTIM STUDY [J].
LUC, G ;
BARD, JM ;
ARVEILER, D ;
EVANS, A ;
CAMBOU, JP ;
BINGHAM, A ;
AMOUYEL, P ;
SCHAFFER, P ;
RUIDAVETS, JB ;
CAMBIEN, F ;
FRUCHART, JC ;
DUCIMETIERE, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (09) :1412-1419
[12]   APOLIPOPROTEIN-E - CHOLESTEROL TRANSPORT PROTEIN WITH EXPANDING ROLE IN CELL BIOLOGY [J].
MAHLEY, RW .
SCIENCE, 1988, 240 (4852) :622-630
[13]   SOLVENT CONTENT OF PROTEIN CRYSTALS [J].
MATTHEWS, BW .
JOURNAL OF MOLECULAR BIOLOGY, 1968, 33 (02) :491-+
[14]   SYNERGISTIC EFFECTS OF TRAUMATIC HEAD-INJURY AND APOLIPOPROTEIN-EPSILON-4 IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
MAYEUX, R ;
OTTMAN, R ;
MAESTRE, G ;
NGAI, C ;
TANG, MX ;
GINSBERG, H ;
CHUN, M ;
TYCKO, B ;
SHELANSKI, M .
NEUROLOGY, 1995, 45 (03) :555-557
[15]   Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli [J].
Morrow, JA ;
Arnold, KS ;
Weisgraber, KH .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (02) :224-230
[16]  
RALL SC, 1986, METHOD ENZYMOL, V128, P273
[17]  
RALL SC, 1982, J BIOL CHEM, V257, P4171
[18]   ASSOCIATION OF APOLIPOPROTEIN-E ALLELE EPSILON-4 WITH LATE-ONSET FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE [J].
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, D ;
GEORGEHYSLOP, PHS ;
PERICAKVANCE, MA ;
JOO, SH ;
ROSI, BL ;
GUSELLA, JF ;
CRAPPERMACLACHLAN, DR ;
ALBERTS, MJ ;
HULETTE, C ;
CRAIN, B ;
GOLDGABER, D ;
ROSES, AD .
NEUROLOGY, 1993, 43 (08) :1467-1472
[19]  
SEGREST JP, 1992, J LIPID RES, V33, P141
[20]   Apolipoprotein E epsilon 4 and the risk of dementia with stroke - A population-based investigation [J].
Slooter, AJC ;
Tang, MX ;
vanDuijn, CM ;
Stern, Y ;
Ott, A ;
Bell, K ;
Breteler, MMB ;
Van Broeckhoven, C ;
Tatemichi, TK ;
Tycko, B ;
Hofman, A ;
Mayeux, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (10) :818-821